A simple and rapid method for removal of specific cell populations from whole blood

Microfluidic system for dielectrophoretic separation based on a trapezoidal electrode array

This paper presents a novel microfluidic device for dielectrophoretic separation based on a trapezoidal electrode array (TEA). In this method, particles with different dielectric properties are separated by the device composed of the TEA for the dielectrophoretic deflection of particles under negative dielectrophoresis (DEP) and poly(dimethylsiloxane)(PDMS) microfluidic channel with a sinuous and expanded region. Polystyrene microparticles are exposed to an electric field generated from the TEA in the microfluidic channel and are dielectrophoretically focused to make all of them line up to one sidewall. When these particles arrive at the region of another TEA for dielectrophoretic separation, they are separated having different positions along the perpendicular direction to the fluid flow due to their different dielectrophoretic velocities. To evaluate the separation process and performance, both the effect of the flow rate on dielectrophoretic focusing and the influence of the number of trapezoidal electrodes on dielectrophoretic separation are investigated. Now that this method utilizes the TEA as a source of negative DEP, non-specific particle adhering to the electrode surface can be prevented; conventional separation approaches depending on the positive DEP force suffer from this problem. In addition, since various particle types are continuously separated, this method can be easily applicable to the separation and analysis of various dielectric particles with high particle recovery and selectivity.

Identification and isolation of hematopoietic stem cells

Hematopoietic stem cells (HSCs) are defined by their ability to repopulate all of the hematopoietic lineages in vivo and sustain the production of these cells for the life span of the individual. In the absence of reliable direct markers for HSCs, their identification and enumeration depends on functional long-term, multilineage, in vivo repopulation assays. The extremely low frequency of HSCs in any tissue and the absence of a specific HSC phenotype have made their purification and characterization a highly challenging goal. HSCs and primitive hematopoietic cells can be distinguished from mature blood cells by their lack of lineage-specific markers and presence of certain other cell-surface antigens, such as CD133 (for human cells) and c-kit and Sca-1 (for murine cells). Functional analyses of purified subpopulations of primitive hematopoietic cells have led to the development of several procedures for isolating cell populations that are highly enriched in cells with in vivo stem cell activity. Simplified methods for obtaining these cells at high yield have been important to the practical exploitation of such advances. This article reviews recent progress in identifying human and mouse HSCs and current techniques for their purification.

Purification of hematopoietic stem cells for further biological study

For many years, the hematopoietic system has provided a convenient and fascinating model for studies of the molecular processes regulating cell growth and differentiation. However, this system also poses considerable challenges because the most primitive "stem" cells as well as their initial differentiating progeny are normally present in hematopoietic tissues at extremely low frequencies and no unique, stable phenotype has yet been identified to allow hematopoietic cells with specific stem and progenitor functions to be measured directly. Rather, this requires the use of functional assays that detect their developmental properties and take several weeks to complete. Accordingly, many investigations of primitive hematopoietic cell behavior and their responses to molecular cues in the environment have relied on the development of cell separation techniques specifically designed for obtaining highly enriched populations of primitive hematopoietic cells. Key to these procedures is the use of a preenrichment step(s) in which differences in cell density, size, or sensitivity to pharmacological agents or surface phenotype are exploited to first "debulk" the sample. This step can then be followed by a more selective antibody-mediated procedure to generate useful numbers of highly purified cells. Batchwise immunoadsorption techniques offer many advantages for obtaining enriched populations of hematopoietic progenitors because they avoid the nonspecific toxicity seen with antibody-mediated cell killing and are suitable for rapidly processing large samples. For any cell separation procedure, a balance must be struck between the purity and the recovery of the desired cells because steps to increase cell purity usually reduce yields. Both the negative and the positive selection techniques are useful strategies but negative selection usually requires one less manipulation step and circumvents potential effects incurred by the presence of antibody on the surface of the cell being isolated. Specific details for the use and results obtained with an immunomagnetic negative column selection technique are then presented.